en-GBlv-LVru-RU
en-GBlv-LVru-RU

2021



 Starptautiski citētās publikācijas

Scopus / Web of Science / PubMed publicētie zinātniskie raksti:

  1. Akyüz, K., Chassang, G., Goisauf, M., Kozera, Ł., Mezinska, S., Tzortzatou, O., & Mayrhofer, M. T. (2021). Biobanking and risk assessment: a comprehensive typology of risks for an adaptive risk governance. Life Sciences, Society and Policy, 17(1), 1-28.
  2. Bornschein J, Tran-Nguyen T, Fernandez-Esparrach G, Ash S, Balaguer F, Bird-Lieberman EL, et al. Biopsy Sampling in Upper Gastrointestinal Endoscopy: A Survey from 10 Tertiary Referral Centres Across Europe. Dig Dis. 2021;39(3):179-89.
  3. Caldas M, Perez-Aisa A, Tepes B, Keco-Huerga A, Bujanda L, Lucendo AJ, et al. The Role of Statins on Helicobacter pylori Eradication: Results from the European Registry on the Management of H. pylori (Hp-EuReg). Antibiotics (Basel). 2021;10(8).
  4. Hammer HF, Fox MR, Keller J, Salvatore S, Basilisco O, Hammer H, et al. European guideline on indications, performance, and clinical impact of hydrogen and methane breath tests in adult and pediatric patients: European Association for Gastroenterology, Endoscopy and Nutrition, European Society of Neurogastroenterology and Motility, and European Society for Paediatric Gastroenterology Hepatology and Nutrition consensus. United European Gastroenterology Journal. 2021:1-26.
  5. Isajevs S, Savcenko S, Liepniece-Karele I, Piazuelo MB, Kikuste I, Tolmanis I, et al. High-risk individuals for gastric cancer would be missed for surveillance without subtyping of intestinal metaplasia. Virchows Arch. 2021;479(4):679-86.
  6. Jaeschke C, Padilla M, Glockler J, Polaka I, Leja M, Veliks V, et al. Modular Breath Analyzer (MBA): Introduction of a Breath Analyzer Platform Based on an Innovative and Unique, Modular eNose Concept for Breath Diagnostics and Utilization of Calibration Transfer Methods in Breath Analysis Studies. Molecules. 2021;26(12).
  7. Karelis G, Micule M, Klavina E, Haritoncenko I, Kikule I, Tilgale B, et al. The Riga East University Hospital Stroke Registry-An Analysis of 4915 Consecutive Patients with Acute Stroke. Medicina (Kaunas). 2021;57(6).
  8. Leiherer A, Slefarska D, Leja M, Heinzle C, Mundlein A, Kikuste I, et al. The Volatilomic Footprints of Human HGC-27 and CLS-145 Gastric Cancer Cell Lines. Front Mol Biosci. 2021;7:607904.
  9. Leja M, Kortelainen JM, Polaka I, Turppa E, Mitrovics J, Padilla M, et al. Sensing gastric cancer via point-of-care sensor breath analyzer. Cancer. 2021;127(8):1286-92.
  10. Leja M, Line A. Early detection of gastric cancer beyond endoscopy - new methods. Best Pract Res Clin Gastroenterol. 2021;50-51:101731.
  11. Megraud F, Bruyndonckx R, Coenen S, Wittkop L, Huang TD, Hoebeke M, et al. Helicobacter pylori resistance to antibiotics in Europe in 2018 and its relationship to antibiotic consumption in the community. Gut. 2021;70(10):1815-22.
  12. Mezinska S, Gallagher L, Verbrugge M, Bunnik EM. Ethical issues in genomics research on neurodevelopmental disorders: a critical interpretive review. Hum Genomics. 2021;15(1):16.
  13. Mezmale L, Polaka I, Rudzite D, Vangravs R, Kikuste I, Parshutin S, et al. Prevalence and Potential Risk Factors of Helicobacter pylori Infection among Asymptomatic Individuals in Kazakhstan. Asian Pac J Cancer Prev. 2021;22(2):597-602.
  14. Mlakar I, Lin S, Aleksandravica I, Arcimovica K, Eglitis J, Leja M, et al. Patients-centered SurvivorShIp care plan after Cancer treatments based on Big Data and Artificial Intelligence technologies (PERSIST): a multicenter study protocol to evaluate efficacy of digital tools supporting cancer survivors. BMC Med Inform Decis Mak. 2021;21(1):243.
  15. Nyssen OP, Bordin D, Tepes B, Perez-Aisa A, Vaira D, Caldas M, et al. European Registry on Helicobacter pylori management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients. Gut. 2021;70(1):40-54.
  16. Nyssen OP, Perez-Aisa A, Tepes B, Castro-Fernandez M, Kupcinskas J, Jonaitis L, et al. Adverse Event Profile During the Treatment of Helicobacter pylori: A Real-World Experience of 22,000 Patients From the European Registry on H. pylori Management (Hp-EuReg). Am J Gastroenterol. 2021;116(6):1220-9.
  17. Parshutin S, Kirshners A, Kornijenko Y, Zabiniako V, Garsparovica-Asite M, Rozkalns A. Classification with LSTM Networks in User Behaviour Analytics with Unbalanced Environment. Aut Control Comp Sci 2021;55:85-91.
  18. Polaka I, Razuka-Ebela D, Park JY, Leja M. Taxonomy-based data representation for data mining: an example of the magnitude of risk associated with H. pylori infection. BioData Min. 2021;14(1):43.
  19. Ricciardiello L, Leja M, Ollivier M. Horizon Europe, the new programme for research & innovation: Which opportunities for GI research in the years to come? United European Gastroenterol J. 2021;9(3):407-9.
  20. Rokkas T, Gisbert JP, Malfertheiner P, Niv Y, Gasbarrini A, Leja M, et al. Comparative Effectiveness of Multiple Different First-Line Treatment Regimens for Helicobacter pylori Infection: A Network Meta-analysis. Gastroenterology. 2021;161(2):495-507 e4.
  21. Simsone Z, Freivalds T, Bema D, Mikelsone I, Patetko L, Berzins J, et al. Cancer microcell initiation and determination. Bmc Cancer. 2021;21(1).
  22. Song L, Song M, Camargo MC, Van Duine J, Williams S, Chung Y, et al. Identification of anti-Epstein-Barr virus (EBV) antibody signature in EBV-associated gastric carcinoma. Gastric Cancer. 2021;24(4):858-67.
  23. Vishinkin R, Busool R, Mansour E, Fish F, Esmail A, Kumar P, et al. Profiles of Volatile Biomarkers Detect Tuberculosis from Skin. Adv Sci (Weinh). 2021;8(15):e2100235.
  24. Zodzika J, Krumina K, Jermakova I, Kojalo U, Plisko O, Santare D, et al. Post-reproductive aged women: a lost generation in the cervical cancer screening programme. Eur J Contracept Reprod Health Care. 2021;26(1):23-8.

 

Starptautiskos žurnālos publicēti raksti:

  1. Leja M, Cine E, Polaka I, Daugule I, Murillo R, Parshutin S, et al. Factors influencing participation in preventive interventions for gastric cancer: the results from the GISTAR study. Eur J Cancer Prev. 2021.
  2. Morais S, Peleteiro B, Araujo N, Malekzadeh R, Ye W, Plymoth A, et al. Identifying the Profile of Helicobacter pylori-Negative Gastric Cancers: A Case-Only Analysis within the Stomach Cancer Pooling (StoP) Project. Cancer Epidemiol Biomarkers Prev. 2021.
  3. Polaka I, Padilla M, Mezmale L, Mitrovics J, Leja M. Class Decomposition for Gastric Cancer Detection from Breath. 62nd International Scientific Conference on Information Technology and Management Science of Riga Technical University (ITMS). 2021:1-5
  4. Sjomina O, Lielause A., Rūdule A., Vangravs R., Paršutins S., Poļaka I., Daugule I., Stonāns I., Young Park J., Leja M., Randomised clinical trial: comparison of efficacy and adverse effects of a standard triple clarithromycin-containing regimen with high-dose amoxicillin and bismuth therapy in Helicobacter pylori eradication; European Journal of Cancer Prevention.

 

Vietējas nozīmes izdevumu raksti:

  1. Mezinska S, Kaleja J, Mileiko I, Peculis R, Santare D, Rovīte V, et al. Pētniecības biobanku parvaldība Latvijā: ētiskie un sociālie aspekti.  . Latvijas Zinātņu Akadēmijas Vēstis A daļa: Humanitārās un sociālās zinātnes. 2021;75(1):39-52.

 

Cita veida publicēšanās (nodaļa enciklopēdijā, grāmatas, mācību grāmatas, metodiskās rekomendācijas):

1. Dr.sc.soc. Signe Mežinska Dr.biol. Vita Rovīte Dr.med. Daiga Šantare: Bioētika vidusskolai Cilvēka izcelsmes bioloģisko paraugu izmantošana pētījumos.

 

Starptautiskos žurnālos publicētas tēzes (Scopus/Wos)

  1. Anarkulova L, Mezmale L, Polaka I, Rotberga LR, Bhandari MP, Mitrovics J, et al. Application of sensor breath analyser for non-invasive detection of gastric cancer. Medicina (Kaunas). 2021;57(Supplement 1):21.
  2. Grakova V, Kokina O, Eglitis J, Leja M. Analysis of Latvian cancer care infrastructure in relation to criteria established in European Union. Medicina (Kaunas). 2021;57(Supplement 1):112.
  3. Kovtanyuk S, Tatarova D, Ikauniece L, Santare D. Predisposition of inflammatory bowel disease in menopausal and postmenopausal women. Medicina (Kaunas). 2021;57(Supplement 1):233.
  4. Mežinska S, Kalēja J, Mileiko I, Peculis R, Rovite V, Šantare D, et al. Ethically and socially responsible governance of research biobanks: evidence-based recommendations for stakeholders. Medicina (Kaunas). 2021;57(Supplement 1):67.
  5. Mitildzans A, Zaluzinska Z, Viluma L, Isajevs S. Increased numbers of CD8+ T-lymphocytes and FOXP3 T-lymphocytes correlated with HPV infection in patients with cervical intraepithelial neoplasia. Medicina (Kaunas). 2021;57(Supplement 1):32.
  6. Nyssen OP, Pérez-Aísa Á, Keco-Huerga A, Castro-Fernández M, Lucendo A, Vaira D, … Leja. M, et al. Experience with single capsule bismuth quadruple therapy in 5,000 patients from the European registry on H. Pylori management (hp-eureg). United European Gastroenterology Journal. 2021;Vol 9 (Supplement 8):P0103, p. 321-322.
  7. Nyssen OP, Pérez-Aísa Á, Vaira D, Fiorini G, Rodrigo L, Keco-Huerga A, … Leja. M, et al. Empirical second-line treatments in europe: results from the European registry on H. Pylori management (hp-eureg). United European Gastroenterology Journal. 2021;Vol 9 (Supplement 8):OP069, p. 52-55.
  8. Nyssen OP, Pérez-Aísa Á, Vaira D, Jonaitis L, Tepeš B, Keco-Huerga A, … Leja. M, et al. Empirical first-line treatment use and effectiveness trends in Europe in the period 2013-2020: results from the European registry on H. Pylori management (hp-eureg). United European Gastroenterology Journal. 2021;Vol 9 (Supplement 8):P0102, p. 320-321.
  9. Nyssen OP, Pérez-Aísa Á, Vaira D, Jonaitis L, Tepeš B, Keco-Huerga A, … Leja. M, et al. First-line empirical H. Pylori eradication therapy in europe: results from 30,000 cases of the European registry on H. Pylori management (hp-eureg). United European Gastroenterology Journal. 2021;Vol 9  (Supplement 8):P0101, p. 319-320.
  10. Rotberga LR, Dzērve Z, Bogdanova I, Isajevs S, Liepniece-Karele I, Kikuste I, et al. Findings from the surveillance upper endoscopies in patients with gastric mucosal dysplasia at the baseline. Medicina (Kaunas). 2021;57(Supplement 1):22.
  11. Rotberga LR, Kikuste I, Anarkulova L, Polaka I, Parshutin S, Daugule I, et al. Reasons for refusing further endoscopic surveillance in patients with diagnosed precancerous gastric lesions. Medicina (Kaunas). 2021;57(Supplement 1):238.
  12. Šantare D, Sondore L, Poļaka I, Parshutin S, Kojalo I, Daugule I. Evaluation of the dietary habits of Jēkabpils inhabitants regarding adherence to Nordic diet recommendations. Medicina (Kaunas). 2021;57(Supplement 1):241.
  13. Zablocka T, Kregere V, Engele I, Pure S, Asere E, Isajevs S. The histopathological features of breast radial scar and adenosis stratified according to BI-RADS-3: a pilot study. Medicina (Kaunas). 2021;57(Supplement 1):211.

 

Citos starptautiskos žurnālos publicētas tēzes

  1. Bhandari MP, Veliks V, Mitrovics J, Padilla M, Šuba O, Svare A, Krupnova I,  Ivanovs Ņ,  Leja M. Potential use of breath VOCs sensors in artificial ventilation machine for COVID-19 patients; ISOCS 2021 Summer Short Course – Smelling COVID-19 – Poster Program; p.4., 2021.
  2. Maravic Z, Fotaki V, Mesalles Naranjo O, Gasenko E, Rawicka I, Ruiz Aguilar P, et al. Insights into the gastric and oesophageal cancer patient experience: Results of a pan-European patient survey. Annals of Oncology. 2021;32(S3):150.
  3. Mezinska S, Rovite V. Governance of Research Biobanks in Latvia: Public Attitudes and Trust. BIOSAMPLES AND BIODATA IN MEDICAL RESEARCH ELSI CHALLENGES. 15; 2021.
  4. Nyssen OP, Perez-Aisa A, Keco-Huerga A, Castro-Fernandez M, Lucendo A, Vaira D, et al. Experience with single capsule bismuth quadruple therapy in 5,000 patients From the European registry on H. pylori management (Hp-EuReg). Microb Health Dis. 2021;3:e612(P02.15):29-30.
  5. Nyssen OP, Perez-Aisa A, Vaira D, Fiorini G, Rodrigo L, Keco-Huerga A, et al. Empirical second-line treatments in Europe: results from The European registry on H. pylori management (Hp-EuReg). Microb Health Dis. 2021;3:e612(P02.14):27-9.
  6. Nyssen OP, Perez-Aisa A, Vaira D, Jonaitis L, Tepes B, Keco-Huerga A, et al. First-line empirical H. pylori eradication therapy in europe: Results from 30,000 cases of the European registry on H. pylori management (Hp-EuReg). Microb Health Dis. 2021;3:e612(P02.12):23-5.
  7. Nyssen OP, Perez-Aisa A, Vaira D, Jonaitis L, Tepes B, Keco-Huerga A, et al. Empirical first-line treatment use and effectiveness trends in Europe In the period 2013-2020: results from the European registry on H. pylori Management (Hp-EuReg). Microb Health Dis. 2021;3:e612(P02.13):25-7.
  8. Puig I, Bordin D, Gasbarrini A, Tepes B, Lerang F, Babayeva G, et al. H. pylori diagnostic tests used in naïve patients: Results from the European registry on H. pylori management (Hp-EuReg). Microb Health Dis. 2021;3:e612(P01.05):7-8.
  9. Razuka-Ebela D, Polaka I, Daugule I, Ebela I, Young Park J, Leja M. Current smoking and H. pylori status is associated with precancerous lesions, missed” by serologic pepsinogen testing. Microb Health Dis. 2021;3:e612(P03.02):50-1.
  10. Rotberga L, Leja M, Isajevs S, Tolmanis I, Piazuelo MB. Findings from the surveillance upper endoscopies in patients with gastric mucosal dysplasia at the baseline. Microb Health Dis. 2021;3:e612(P03.13):57.
  11. Rotberga L, Leja M, Kikuste I, Polaka I, Park JY. Reasons for refusing further endoscopic surveillance in patients with diagnosed precancerous gastric lesions. Microb Health Dis. 2021;3:e612(P03.11):56.
  12. Sjomina O, Suhorukova J, Rudule A, Vangravs R, Pupola D, Parshutin S, et al. Addition of Saccharomyces Boulardii to standard triple therapy In eradication of H. Pylori: adverse events and compliance. Microb Health Dis. 2021;3:e612(P02.30):42-3.
  13. Sjomina O, Suhorukova J, Rudule A, Vangravs R, Pupola D, Parshutin S, et al. Comparison of the adverse events and compliance to standard triple therapy in eradication of H.pylori with Saccharomyces boulardii addition. GASTRO 2021 Prague Abstract book. p.190, 2021.
  14. Slefarska D, Mezmale L, Kikuste I, Leja M, Mochalski P. EX-VIVO profiling of volatile organic compounds released from gastric cancer and non-cancerous tissue. Microb Health Dis. 2021;3:e612(P03.08):54.
  15. Sondore L, Indriksone-Gromova I, Daugule I, Polaka I, Parshutin S, Kojalo I, et al. Analysis of dietary habits in Latvian general population in respect to adherence to Mediterranean diet. Rīga Stradiņš University the 8th International Multidisciplinary Research Conference “Society Health Welfare” Abstracts. 2021. Poster presentation

 

Ziņojumi starptautiskās konferencēs

Mutiskie ziņojumi:

  1. Anarkulova L, Mezmale L, Polaka I, Rotberga LR, Bhandari MP, Mitrovics J, et al. Application of sensor breath analyser for non-invasive detection of gastric cancer. International Scientific Conference on Medicine organized within the frame of the 79th International Scientific Conference of the University of Latvia, Riga, online on 23-24 April 2021.
  2. Bhandari MP, Veliks V, Mitrovics J, Padilla M, Šuba O, Svare A, Krupnova I,  Ivanovs Ņ,  Leja M. Potenciālais GOS sensoru pielietojums plaušu mākslīgās ventilācijas iekārtā Covid-19 pacientu monitorēšanai | Potential use of breath VOCs sensors in artificial ventilation machine for COVID-19 patients. 79th International Scientific Conference of University of Latvia. March 10, 2021. Riga, Latvia.
  3. Bhandari MP, Veliks V, Mitrovics J, Padilla M, Šuba O, Svare A, Krupnova I,  Ivanovs Ņ,  Leja M. Potential use of breath VOCs sensors in artificial ventilation machine for COVID-19 patients; 27.05.2021.; ISOCS 2021 Summer Short Course – Smelling COVID-19.
  4. Grakova V, Kokina O, Eglitis J, Leja M. Analysis of Latvian cancer care infrastructure in relation to criteria established in European Union. International Scientific Conference on Medicine organized within the frame of the 79th International Scientific Conference of the University of Latvia, Riga, online on 23-24 April 2021.
  5. Mezinska S, Kalēja J, Mileiko I, Peculis R, Rovite V, Santare D, et al. Ethically and socially responsible governance of research biobanks: evidence-based recommendations for stakeholders. International Scientific Conference on Medicine organized within the frame of the 79th International Scientific Conference of the University of Latvia, Riga, online on 23-24 April 2021.
  6. Mezinska S, Rovite V. Governance of Research Biobanks in Latvia: Public Attitudes and Trust. Biosamples and Biodata in Medical Research: ELSI Challenges, Polija, tiešsaiste 24-26.11.2021
  7. Mitildzans A, Zaluzinska Z, Viluma L, Isajevs S. Increased numbers of CD8+ T-lymphocytes and FOXP3 T-lymphocytes correlated with HPV infection in patients with cervical intraepithelial neoplasia. Medicina (Kaunas). International Scientific Conference on Medicine organized within the frame of the 79th International Scientific Conference of the University of Latvia, Riga, online on 23-24 April 2021.
  8. Nyssen OP, Pérez-Aísa Á, Vaira D, Fiorini G, Rodrigo L, Keco-Huerga A, … Leja. M, et al. Empirical second-line treatments in europe: results from the European registry on H. Pylori management (hp-eureg). 29th United European Gastroenterology Week Virtual 2021; 3.-5.10.2021.
  9. Rotberga LR, Dzērve Z, Bogdanova I, Isajevs S, Liepniece-Karele I, Kikuste I, et al. Findings from the surveillance upper endoscopies in patients with gastric mucosal dysplasia at the baseline. International Scientific Conference on Medicine organized within the frame of the 79th International Scientific Conference of the University of Latvia, Riga, online on 23-24 April 2021.

 

Stenda referāti:

  1. Kovtanyuk S, Tatarova D, Ikauniece L, Santare D. Predisposition of inflammatory bowel disease in menopausal and postmenopausal women. Medicina (Kaunas).  International Scientific Conference on Medicine organized within the frame of the 79th International Scientific Conference of the University of Latvia, Riga, online on 23-24 April 2021.
  2. Maravic Z, Fotaki V, Mesalles Naranjo O, Gasenko E, Rawicka I, Ruiz Aguilar P, et al. Insights into the gastric and oesophageal cancer patient experience: Results of a pan-European patient survey. ESMO - World Congress on Gastrointestinal Cancer, 30.06.-03.07.2021.
  3. Norman G.L, Bentow C, Shum Z, Leja M, Mahler M, Comparison of native vs recombinant ttg iga elisas as an aid in the diagnosis of celiac disease; The 12th International Congress on Autoimmunity, Athens, 28.05.-01.06.2021.
  4. Nyssen OP, Perez-Aisa A, Keco-Huerga A, Castro-Fernandez M, Lucendo A, Vaira D, et al. Experience with single capsule bismuth quadruple therapy in 5,000 patients From the European registry on H. pylori management (Hp-EuReg). EHMSG – 34th International Workshop on Helicobacter & Microbiota in Inflammation & Cancer Virtual Conference, 12 September 2021.
  5. Nyssen OP, Pérez-Aísa Á, Keco-Huerga A, Castro-Fernández M, Lucendo A, Vaira D, … Leja. M, et al. Experience with single capsule bismuth quadruple therapy in 5,000 patients from the European registry on H. Pylori management (hp-eureg). 29th United European Gastroenterology Week Virtual 2021; 3.-5.10.2021.
  6. Nyssen OP, Perez-Aisa A, Vaira D, Fiorini G, Rodrigo L, Keco-Huerga A, et al. Empirical second-line treatments in Europe: results from The European registry on H. pylori management (Hp-EuReg). EHMSG – 34th International Workshop on Helicobacter & Microbiota in Inflammation & Cancer Virtual Conference, 12 September 2021.
  7. Nyssen OP, Perez-Aisa A, Vaira D, Jonaitis L, Tepes B, Keco-Huerga A, et al. First-line empirical H. pylori eradication therapy in europe: Results from 30,000 cases of the European registry on H. pylori management (Hp-EuReg). EHMSG – 34th International Workshop on Helicobacter & Microbiota in Inflammation & Cancer Virtual Conference, 12 September 2021.
  8. Nyssen OP, Perez-Aisa A, Vaira D, Jonaitis L, Tepes B, Keco-Huerga A, et al. Empirical first-line treatment use and effectiveness trends in Europe In the period 2013-2020: results from the European registry on H. pylori Management (Hp-EuReg). EHMSG – 34th International Workshop on Helicobacter & Microbiota in Inflammation & Cancer Virtual Conference, 12 September 2021.
  9. Nyssen OP, Pérez-Aísa Á, Vaira D, Jonaitis L, Tepeš B, Keco-Huerga A, … Leja. M, et al. Empirical first-line treatment use and effectiveness trends in Europe in the period 2013-2020: results from the European registry on H. Pylori management (hp-eureg). 29th United European Gastroenterology Week Virtual 2021; 3.-5.10.2021.
  10. Nyssen OP, Pérez-Aísa Á, Vaira D, Jonaitis L, Tepeš B, Keco-Huerga A, … Leja. M, et al. First-line empirical H. Pylori eradication therapy in europe: results from 30,000 cases of the European registry on H. Pylori management (hp-eureg). 29th United European Gastroenterology Week Virtual 2021; 3.-5.10.2021.
  11. Puig I, Bordin D, Gasbarrini A, Tepes B, Lerang F, Babayeva G, et al. H. pylori diagnostic tests used in naïve patients: Results from the European registry on H. pylori management (Hp-EuReg). EHMSG – 34th International Workshop on Helicobacter & Microbiota in Inflammation & Cancer Virtual Conference, 12 September 2021.
  12. Razuka-Ebela D, Polaka I, Daugule I, Ebela I, Young Park J, Leja M. Current smoking and H. pylori status is associated with precancerous lesions, missed” by serologic pepsinogen testing. EHMSG – 34th International Workshop on Helicobacter & Microbiota in Inflammation & Cancer Virtual Conference, 12 September 2021.
  13. Rotberga L, Leja M, Isajevs S, Tolmanis I, Piazuelo MB. Findings from the surveillance upper endoscopies in patients with gastric mucosal dysplasia at the baseline. EHMSG – 34th International Workshop on Helicobacter & Microbiota in Inflammation & Cancer Virtual Conference, 12 September 2021.
  14. Rotberga L, Leja M, Kikuste I, Polaka I, Park JY. Reasons for refusing further endoscopic surveillance in patients with diagnosed precancerous gastric lesions. EHMSG – 34th International Workshop on Helicobacter & Microbiota in Inflammation & Cancer Virtual Conference, 12 September 2021.
  15. Rotberga LR, Kikuste I, Anarkulova L, Polaka I, Parshutin S, Daugule I, et al. Reasons for refusing further endoscopic surveillance in patients with diagnosed precancerous gastric lesions. International Scientific Conference on Medicine organized within the frame of the 79th International Scientific Conference of the University of Latvia, Riga, online on 23-24 April 2021.
  16. Santare D, Sondore L, Polaka I, Parshutin S, Kojalo I, Daugule I. Evaluation of the dietary habits of Jēkabpils inhabitants regarding adherence to Nordic diet recommendations. International Scientific Conference on Medicine organized within the frame of the 79th International Scientific Conference of the University of Latvia, Riga, online on 23-24 April 2021.
  17. Sjomina O, Suhorukova J, Rudule A, Vangravs R, Pupola D, Parshutin S, et al. Comparison of the adverse events and compliance to standard triple therapy in eradication of H.pylori with Saccharomyces boulardii addition. GASTRO 2021 Prague; A joint meeting WHO/CSG; 9. -11.december 2021.
  18. Sjomina O, Suhorukova J, Rudule A, Vangravs R, Pupola D, Parshutin S, et al. Addition of Saccharomyces Boulardii to standard triple therapy In eradication of H. Pylori: adverse events and compliance. EHMSG – 34th International Workshop on Helicobacter & Microbiota in Inflammation & Cancer Virtual Conference, 12 September 2021.
  19. Slefarska D, Mezmale L, Kikuste I, Leja M, Mochalski P. EX-VIVO profiling of volatile organic compounds released from gastric cancer and non-cancerous tissue. EHMSG – 34th International Workshop on Helicobacter & Microbiota in Inflammation & Cancer Virtual Conference, 12 September 2021.
  20. Zablocka T, Kregere V, Engele I, Pure S, Asere E, Isajevs S. The histopathological features of breast radial scar and adenosis stratified according to BI-RADS-3: a pilot study. International Scientific Conference on Medicine organized within the frame of the 79th International Scientific Conference of the University of Latvia, Riga, online on 23-24 April 2021.

 

Lekcijas, uzstāšanās starptautiskās organizācijās, semināros un pasākumos

  1. Leja Mārcis, Data collaborative in gastric cancer and precancerous lesions: “Multidisciplināra pieeja gastroenteroloģijā”; 10.-11.09.; Sanktpēterburga;
  2. Leja Marcis, presentation “Data Colaborative Project” in HEALTH DATA SUMMIT RIGA 2021: DIGITAL LEAP FOR IMPROVED PATIENT CARE; 26.11.2021.;
  3. Leja Marcis, presentation in European Cancer summit 2021; Session: Advancing the Vision of Comprehensive Cancer Care in Europe; 17.-18.11.2021.
  4. Leja Mārcis. Lekcija. “Vēža misijas rekomendācijas un plāns šo rekomendāciju ieviešanai”. Eiropas Apvienotā Gastroenteroloģijas nedēļa (UEGW) tiešsaiste,  03.10.2021. - 05.10.2021.
  5. Leja Mārcis. Prezentācija “Gastric and oesophageal cancer prevention: What are the challenges and where are we now?” DiCE Masterclass; Eiropas pacientu organizācijas Digestive Cancers Europe meistarklase; 15.04.2021.
  6. Leja Mārcis. Prezentācija “Gastric Cancer Screening Trial evidence”; 21.2021. ASV; SAPEA Science advice for policy by European academies.
  7. Leja Mārcis. Prezentācija M. Leja, R. Murillo, J. Mitrovics, P. Mochalski, B. Mizaikoff, L. Mežmale, A. Corvalán, E. Dias-Neto, I. Poļaka, M. Bhandari, V. Patsko, A .Lukashenko, J.M. Kortelainen, L. Österlund, V. Ikkonen, G. Shani, H. Haick “Breath volatile organic marker sensor-testing for gastric cancer screening”; Affordable Cancer Technologies (ACT) Conference; Sept. 23.-24., 2021
  8. Leja Marcis; CRC Screening. Typical mistakes when starting a CRC screening program; GASTRO 2021 PRAGUE; 10.12.2021.
  9. Leja Marcis; Presentation “The Mission coordination actions at national level” Webinar Conquering Cancer Mission – possible: coordination of actions in the Baltic States” 16.12.2021.
  10. Leja Mārcis; Presentation “European Cancer Mission Board recommendations and the Implementation Plan.” Central-Eastern European Oncology meets Western-Northern-Southern European Oncology: Clinical Trial Activities International Conference Budapest, November 4-5. 2021.
  11. Leja Mārcis; Presentation “Mistakes in gastric cancer screening" (in Russian). Autumn course on acid-related diseases by the Society of gastroenterologists and hepatologists "Noth-East' StPetersburg, November 16 2021.
  12. Mežinska Signe. Prezentācija “Collecting information about donor's relatives for a biobank: ethical issues and unanswered questions”. The 2nd IBCQ International Biobanking Conference 2021, tiešsaiste, 08.03.2021. - 10.03.2021.
  13. Pčolkins Andrejs “Towards comprehensive cancer care in Latvia”; Warsaw Summit of European Cancer Strategies; 09.12.2021. 

 

Lekcijas, uzstāšanās vietēja mēroga organizācijās, semināros un pasākumos

  1. Arcimoviča Krista “PERSIST - uz vēzi pārdzīvojušiem pacientiem orientēts aprūpes plāns, kas ir balstīts uz Lielo datu un mākslīgā intelekta tehnoloģijām” prezentācija preses konferencē par aktualitātēm vēža pacientu pēcaprūpē un starptautiskā inovatīvo tehnoloģiju projekta PERSIST norisi 28.10.2021.
  2. Bēma Dina “Current standing of PERSIST: Clinical studies” prezentācija konsorcija informatīvajā pasākumā “A Look Beyound Europe`s Beating Cancer Plan” 30.06.2021.
  3. Bhandari Manohar Prasad “”Volatile organic compound in human exhaled breath to diagnose gastric cancer”; Doktorantūras skola “Translācijas medicīna” online 06.10.2021.
  4. Bhandari Manohar Prasad “Kuņģa mikrobioma un gaistošo organisko savienojumu sakarības izpēte agrīnai kuņģa vēža diagnostikai.” Zināšanu Agora, LU 23.09.2021.
  5. Bhandari Manohar Prasad, presentation about the progress of the postdoctoral project activities at a meeting of the Council of Medical Sciences, “Study of relation between gastric microbiota and VOCs for the early detection of gastric cancer”, University of Latvia. LU, Riga, 23 September 2021
  6. Daugule Ilva: “Ieskats translācijas izpētes medicīnā: telemedicīna, televeselība un attālinātās medicīnas ētiskie aspekti”; Doktorantūras skola “Translācijas medicīna” online 06.10.2021.
  7. Mežinska Signe. Prezentācija “Atbildīga amatierzinātne digitālajā vidē”. UNESCO Latvijas Nacionālās komisijas konference "Vērtību griežos: ētiskie izaicinājumi virtuālajā un reālajā pasaulē", Rīga, Latvija, 22.10.2021.
  8. Mežinska Signe: Festivāla LAMPA diskusija "Kibercilvēki 2030: cieņa pret dabisko evolūciju vs tehnoloģiju radītās iespējas uzlabot cilvēku” 21.08.2021.
  9. Mežinska Signe; Pacientu organizāciju koference "Skaļrunis", uzstāšanās "Pacients, ārsts un informācija. Kā saprast un saprasties? " 11.09.2021.
  10. Mežinska Signe; Zinātnieku nakts 2021 diskusija “Sabiedriskā zinātne (Citizen Science). Quo Vadis?", uzstāšanās “Zinātnes ētika sabiedriskajā zinātnē”. 30.04.2021.
  11. Pčolkins Andrejs “Ķirurģisko komplikāciju profilakse kolorektālā vēža ķirurģijā, veicot mehānisko zarnu sagatavošanu kopā ar neuzsūcošām antibiotikām”; Doktorantūras skola “Translācijas medicīna” online 30.04.2021.
  12. Poļaka Inese “Kāpēc nepieciešama daudzpakāpju statistiskā analīze?”; Doktorantūras skola “Translācijas medicīna” online 24.11.2021.
  13. Polaka Inese; “Datizraces un mašīnmācīšanās pieeju izmantošana pētījumu datu analīzē”; Doktorantūras skola “Translācijas medicīna” online 12.03.2021.
  14. Šantare Daiga; online lekcija “Veselīgs uzturs pacientiem pēc vēža ārstēšanas” PERSIST pētījuma dalībniekiem 14.10.2021.
  15. Šantare Daige “Ziemeļvalstu diēta un zarnu mikrobiotas īpatnības”; Doktorantūras skola “Translācijas medicīna” online 15.12.2021.
  16. Sondore Liene: “Ziemeļvalstu diētas ietekme uz slimību riska faktoriem”; Doktorantūras skola “Translācijas medicīna” 05.02.2021.
  17. Vangravs Reinis: “Ievads mikrobioma pētniecībā” 25.11.2021. Mikrobiotas skola.
  18. Vangravs Reinis: “Mikrobioma sekvencēšanas un datu analīzes pamati” 09.12.2021. Mikrobiotas skola.
Copyright 2016 - 2022 by LU KPMI